Sarcoma treatment in the era of molecular medicine-Reference-Cited by-同舟云学术

Sarcoma treatment in the era of molecular medicine

Published:2020-10-13 Issue:11 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Grünewald Thomas GP¹²³^ORCID,Alonso Marta⁴^ORCID,Avnet Sofia⁵,Banito Ana⁶,Burdach Stefan⁷,Cidre‐Aranaz Florencia¹^ORCID,Di Pompo Gemma⁵,Distel Martin⁸,Dorado‐Garcia Heathcliff⁹,Garcia‐Castro Javier¹⁰,González‐González Laura¹⁰,Grigoriadis Agamemnon E¹¹,Kasan Merve¹,Koelsche Christian³,Krumbholz Manuela¹²,Lecanda Fernando¹³,Lemma Silvia⁵,Longo Dario L¹⁴,Madrigal‐Esquivel Claudia¹⁵,Morales‐Molina Álvaro¹⁰,Musa Julian¹¹⁶,Ohmura Shunya¹,Ory Benjamin¹⁷,Pereira‐Silva Miguel¹⁸,Perut Francesca⁵,Rodriguez Rene¹⁹²⁰^ORCID,Seeling Carolin²¹,Al Shaaili Nada¹⁵,Shaabani Shabnam²²,Shiavone Kristina¹⁵,Sinha Snehadri²³,Tomazou Eleni M⁸,Trautmann Marcel²⁴^ORCID,Vela Maria²⁵,Versleijen‐Jonkers Yvonne MH²⁶,Visgauss Julia²⁷,Zalacain Marta¹⁴,Schober Sebastian J⁷,Lissat Andrej²⁸,English William R¹⁵,Baldini Nicola⁵²⁹^ORCID,Heymann Dominique¹⁵³⁰^ORCID

Affiliation:

1. Max‐Eder Research Group for Pediatric Sarcoma Biology Institute of Pathology Faculty of Medicine LMU Munich Munich Germany

2. Division of Translational Pediatric Sarcoma Research German Cancer Research Center (DKFZ), Hopp Children's Cancer Center (KiTZ), German Cancer Consortium (DKTK) Heidelberg Germany

3. Institute of Pathology Heidelberg University Hospital Heidelberg Germany

4. Program in Solid Tumors and Biomarkers Foundation for the Applied Medical Research University of Navarra Pamplona Pamplona Spain

5. Orthopedic Pathophysiology and Regenerative Medicine Unit IRCCS Istituto Ortopedico Rizzoli Bologna Italy

6. Pediatric Soft Tissue Sarcoma Research Group German Cancer Research Center (DKFZ) Heidelberg Germany

7. Department of Pediatrics and Children's Cancer Research Center (CCRC) Technische Universität München Munich Germany

8. Children's Cancer Research Institute Vienna Austria

9. Department of Pediatric Oncology/Hematology Charité‐Universitätsmedizin Berlin Berlin Germany

10. Cellular Biotechnology Unit Instituto de Salud Carlos III Madrid Spain

11. Centre for Craniofacial and Regenerative Biology King's College London London UK

12. Department of Pediatrics University Hospital Erlangen Germany

13. Division of Oncology Adhesion and Metastasis Laboratory Center for Applied Medical Research University of Navarra Pamplona Spain

14. Institute of Biostructures and Bioimaging (IBB) Italian National Research Council (CNR) Turin Italy

15. Department of Oncology and Metabolism University of Sheffield Sheffield UK

16. Department of General, Visceral and Transplantation Surgery University of Heidelberg Heidelberg Germany

17. Université de Nantes, Inserm, U1238 Nantes France

18. Department of Pharmaceutical Technology Faculty of Pharmacy University of Coimbra Coimbra Portugal

19. Instituto de Investigación Sanitaria del Principado de Asturias Oviedo Spain

20. CIBER en oncología (CIBERONC) Madrid Spain

21. Institute of Pathology Ulm University Ulm Germany

22. Department of Drug Design University of Groningen Groningen The Netherlands

23. Department of Oral and Maxillofacial Diseases University of Helsinki Helsinki Finland

24. Division of Translational Pathology Gerhard‐Domagk‐Institute of Pathology Münster University Hospital Münster Germany

25. Hospital La Paz Institute for Health Research (IdiPAZ) Madrid Spain

26. Department of Medical Oncology Radboud University Medical Center Nijmegen The Netherlands

27. Medical Center Duke University Durham NC USA

28. University Children′s Hospital Zurich – Eleonoren Foundation Kanton Zürich Zürich Switzerland

29. Department of Biomedical and Neuromotor Sciences University of Bologna Bologna Italy

30. Université de Nantes Institut de Cancérologie de l'Ouest Tumor Heterogeneity and Precision Medicine Saint‐Herblain France

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201911131

Reference452 articles.

1. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies

2. Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

3. Amputation for extremity soft tissue sarcoma does not increase overall survival: A retrospective cohort study

4. Bone microenvironment signals in osteosarcoma development

5. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03

2. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization;Neoplasia;2024-02

3. YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells;Frontiers in Oncology;2024-01-31

4. The causal relationship between gut microbiota and two neoplasms, malignant and benign neoplasms of bone and articular cartilage: a two-sample mendelian randomization study;2024-01-18

5. Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors;Virchows Archiv;2024-01-16